Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Artificial intelligence (AI) -powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of prognosis in stage II-III resectable colon cancer.
Authors
Yoojoo Lim
Lunit Inc., Seoul, South Korea;
Yoojoo Lim , Songji Choi , Hyeon Jeong Oh , Sanghoon Song , Sukjun Kim , Heon Song , Seonwook Park , Ji-Won Kim , Jin Won Kim , Jee Hyun Kim , Minsu Kang , Sung-Bum Kang , Duck-Woo Kim , Heung-Kwon Oh , Hye Seung Lee , Keun-Wook Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 211)
DOI
10.1200/JCO.2023.41.4_suppl.211
Abstract #
211
Poster Bd #
L13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.
First Author: David Viñal
Poster
2018 ASCO Annual Meeting
Prognostic value of tumour infiltrating lymphocytes in stage II colon cancer. A nationwide population-based study.
First Author: Ann Christina Eriksen
Poster
2017 ASCO Annual Meeting
Recurrence risk factors and outcome stratification in stage II colon cancer patients: A subanalysis of the SACURA trial.
First Author: Megumi Ishiguro
Poster
2017 Gastrointestinal Cancers Symposium
A retrospective analysis on the impact of preoperative neutrophil to lymphocyte ratio in stage II colon cancer.
First Author: Deepna Jaiswal